Altered mRNA abundance of ASB15 and four other genes in skeletal muscle following administration of beta-adrenergic receptor agonists.
about
Ankyrin repeat and suppressors of cytokine signaling box protein asb-9 targets creatine kinase B for degradationExpression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm.ASB9 interacts with ubiquitous mitochondrial creatine kinase and inhibits mitochondrial functionChanges in skeletal muscle gene expression following clenbuterol administration.Ankyrin repeat and SOCS box containing protein 4 (Asb-4) interacts with GPS1 (CSN1) and inhibits c-Jun NH2-terminal kinase activity.The E3 ubiquitin ligase specificity subunit ASB2α targets filamins for proteasomal degradation by interacting with the filamin actin-binding domainGenome-wide association study of short-acting β2-agonists. A novel genome-wide significant locus on chromosome 2 near ASB3.Role of beta-adrenoceptor signaling in skeletal muscle: implications for muscle wasting and disease.Thousands of exon skipping events differentiate among splicing patterns in sixteen human tissues.Promoter analysis and tissue expression of the chicken ASB15 gene.Ankyrin repeat and SOCS box protein 15 regulates protein synthesis in skeletal muscle.Identification of transcriptional biomarkers by RNA-sequencing for improved detection of β2-agonists abuse in goat skeletal muscle.Bayesian recursive mixed linear model for gene expression analyses with continuous covariates.Polymorphisms of Flanking Region of the ASB15 Gene and Their Associations with Performance Traits in Chicken.
P2860
Q24322983-2BE0ABA3-B563-40C0-A637-2F1A36D59EFFQ30157109-B6B52947-DB66-4F95-9897-6515653F74B4Q30494036-1C4D0D4B-A228-437C-BB01-BAC9BE37AC19Q33267204-19104C58-5109-4026-A2D0-5099BE499300Q33271822-B605E316-3C21-4F01-A749-C22F5D6D51BEQ35112298-B82C4C3B-858C-403C-9461-2E0AAB074C99Q35261929-AA8E1AEB-C7DF-4D7C-A722-7EDDAB1A95FCQ37129351-34B2B14B-1097-49DF-AA09-ACF180002B83Q37482993-1A524109-584C-4E23-8DE2-5465E243CDA4Q39187390-6FCC7B48-DE61-4242-B262-1C7929265625Q40327490-B14CC763-ADBA-4E5C-90B2-9948C024251FQ41137015-5B798F44-1F03-4740-B002-E687AD813D6DQ46056163-5CAA96EA-97BD-4E56-9362-0DB23C35EAA4Q51398530-51F66521-237B-4F8F-9653-BDDDAAF0DB2A
P2860
Altered mRNA abundance of ASB15 and four other genes in skeletal muscle following administration of beta-adrenergic receptor agonists.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Altered mRNA abundance of ASB1 ...... -adrenergic receptor agonists.
@en
Altered mRNA abundance of ASB1 ...... -adrenergic receptor agonists.
@nl
type
label
Altered mRNA abundance of ASB1 ...... -adrenergic receptor agonists.
@en
Altered mRNA abundance of ASB1 ...... -adrenergic receptor agonists.
@nl
prefLabel
Altered mRNA abundance of ASB1 ...... -adrenergic receptor agonists.
@en
Altered mRNA abundance of ASB1 ...... -adrenergic receptor agonists.
@nl
P2093
P2860
P1476
Altered mRNA abundance of ASB1 ...... -adrenergic receptor agonists.
@en
P2093
Deana L Hancock
Diane E Moody
Tara G McDaneld
P2860
P304
P356
10.1152/PHYSIOLGENOMICS.00127.2003
P577
2004-01-15T00:00:00Z